Cardiff Oncology, Inc. (CRDF)
1.58
-0.02
(-1.25%)
USD |
NASDAQ |
Feb 12, 16:00
1.57
-0.01
(-0.63%)
After-Hours: 20:00
Cardiff Oncology EPS Diluted (Quarterly) : -0.1684 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Windtree Therapeutics, Inc. | -1.085 |
| Enzon Pharmaceuticals, Inc. | -0.0183 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.26M |
| Revenue (Quarterly) | 0.12M |
| Total Expenses (Quarterly) | 11.38M |
| Enterprise Value | 46.85M |
| Gross Profit Margin (Quarterly) | -86.67% |
| Profit Margin (Quarterly) | -9.38K% |
| Earnings Yield | -50.23% |
| Normalized Earnings Yield | -50.23 |